The two panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD) using next-generation sequencing.

The RainDance ASDSeq and XSeq panels are based on the company’s microdroplet-based targeted sequencing technology, which features the coverage for detecting mutations central to understanding these types of disorders.

Emory Genetics Laboratory senior director and Emory University School of Medicine Department of Human Genetics associate professor Madhuri Hegde said the RainDance panels enable them to apply next-generation sequencing more routinely to projects focused on the specific genetic mutations that contribute to autism and other X-linked disorders.